Published in Radiology on July 01, 1969
Postradiation lower motor neuron syndrome presenting as monomelic amyotrophy. J Neurol Neurosurg Psychiatry (1991) 1.27
Isolated lower motoneuron involvement following radiotherapy. J Neurol Neurosurg Psychiatry (1986) 0.93
Pathology of radiation myelopathy. J Neurol Neurosurg Psychiatry (1972) 0.84
Radiation myelopathy. J Neurol Neurosurg Psychiatry (1979) 0.83
Post radiation monomelic amyotrophy. J Neurol Neurosurg Psychiatry (1992) 0.79
Late onset radiation-induced motor neuron syndrome. J Neurol Neurosurg Psychiatry (1992) 0.78
Post-irradiation lumbosacral radiculopathy associated with multiple cavernous malformations of the cauda equina: Case report and review of the literature. Surg Neurol Int (2017) 0.75
Lumbosacral plexopathy: A rare long term complication of concomitant chemo-radiation for cervical cancer. Gynecol Oncol Res Pract (2015) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J (1978) 3.59
Staging and natural history of cerebrovascular pathology in dementia. Neurology (2012) 2.61
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 2.47
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology (1999) 2.00
Necropsy evidence of central cholinergic deficits in senile dementia. Lancet (1977) 1.97
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Letter: Unusual cardiac and neurological reactions to narcotics. Lancet (1973) 1.90
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci (1977) 1.83
Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol (1978) 1.82
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med (1992) 1.49
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry (2001) 1.44
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol (2006) 1.29
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol (1994) 1.28
An evaluation of lymphadenectomy in the treatment of malignant testicular germ cell neoplasms. J Urol (1969) 1.26
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry (1994) 1.18
An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology (1994) 1.18
Clinically and neuropathologically distinct form of dementia in the elderly. Lancet (1989) 1.16
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett (1982) 1.14
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) (1981) 1.11
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res (2007) 1.10
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci Lett (1997) 1.08
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
Proceedings: Radiation therapy in malignant testis tumors. I: Seminoma; II: Carcinoma. Cancer (1973) 1.08
Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res (2004) 1.08
Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett (1980) 1.06
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci (1981) 1.05
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett (1983) 1.05
Experimental stroke and neuroprotection in the aging rat brain. Stroke (1995) 1.04
The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett (1982) 1.04
Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect (1990) 1.03
Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem Pathol (1985) 1.03
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol (2004) 1.03
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience (1998) 1.02
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology (2004) 1.02
Seminoma of the testis: analysis of treatment success and failure. Am J Roentgenol Radium Ther Nucl Med (1968) 1.00
Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem (1986) 1.00
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn (1995) 0.99
Metabolically active synaptosomes can be prepared from frozen rat and human brain. J Neurochem (1983) 0.99
Detection of Lewy bodies in Trisomy 21 (Down's syndrome). Can J Neurol Sci (1993) 0.99
Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res (1998) 0.99
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience (2000) 0.98
Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol (1991) 0.98
Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem (1999) 0.97
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem (1990) 0.97
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry (1987) 0.96
Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry (1983) 0.96
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer (1995) 0.95
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology (2004) 0.95
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci (2001) 0.94
Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord (1999) 0.94
Federal prison residential drug treatment reduces substance use and arrests after release. Am J Drug Alcohol Abuse (2001) 0.94
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res (1997) 0.93
Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type. Lancet (1982) 0.93
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain (1991) 0.93
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology (2000) 0.92
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat (1984) 0.92
Four primary tumors in one child. Cancer (1983) 0.91
5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord (1987) 0.91
Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet (1983) 0.91
[3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging. Brain Res (1992) 0.91
Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol (2009) 0.90
Recent advances in neuropathology. Br Med Bull (1986) 0.90
Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry (2000) 0.90
Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J Neurochem (1998) 0.89
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging (1981) 0.89
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. J Neurol Sci (1984) 0.89
Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J Chem Neuroanat (2003) 0.89
Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. J Neurol Sci (1985) 0.89
Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging (1992) 0.89
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia (1994) 0.89
Cholinergic receptors in cognitive disorders. Can J Neurol Sci (1986) 0.89
Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci (1983) 0.88
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet (1998) 0.88
Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man. J Neurol (2003) 0.88
Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease. Ciba Found Symp (1986) 0.88
Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. Age Ageing (1980) 0.88
Treatment and prognosis in Wilms' tumor. A study of 51 cases with special reference to the role of actinomycin D. Cancer (1967) 0.87
Solitary extranodal lymphoma of sciatic nerve. J Neurol Sci (1986) 0.87
Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur J Neurosci (1999) 0.86
Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiol Dis (2005) 0.86
p53 protein expression in ductal carcinoma in situ (DCIS) of the breast. Breast Cancer Res Treat (1997) 0.85